On this page
⚠ Educational content only Not medical or genetic advice. Speak with a healthcare provider or genetic counsellor before acting on anything here.

USH2A

usherin

Chromosome 1q41 Various HGNC:12601 Tier C
USH2A 1q41 p arm q arm 1

USH2A is located on the long (q) arm of chromosome 1, at band 1q41. Arm ratio per GRCh38 - banding schematic.

Explore chromosome 1 in the library →

Available at Jeen Health

Clinical tests that include this

Overview

The USH2A gene is located on chromosome 1 and encodes usherin, a protein integral to the structural scaffolding of basement membranes in sensory tissues. Basement membranes are thin, sheet-like structures that provide support and organisation to cells, and usherin plays a particularly important role in the inner ear and retina. Pathogenic changes in USH2A are the most frequent cause of Usher syndrome type 2, a condition combining congenital hearing loss with progressive retinal degeneration. USH2A variants also account for a substantial proportion of autosomal recessive retinitis pigmentosa cases without associated hearing impairment. Understanding this gene is essential for families affected by inherited sensory disorders and informs clinical pathways for early detection and management.

What the gene does

Usherin functions as a structural component within basement membranes, the extracellular matrices that separate and support epithelial and other tissue layers. Research suggests that usherin participates in a multi-protein complex essential for the development and long-term maintenance of hair cells in the cochlea and photoreceptor cells in the retina. These sensory cells are highly specialised and depend on precise structural organisation to function correctly. Evidence indicates that usherin may also contribute to synaptic function at junctions between nerve cells, where signals are transmitted during sensory processing. The protein's presence in both auditory and visual tissues explains why USH2A variants typically affect both hearing and sight, though the timing and severity of involvement can vary. Loss of functional usherin disrupts the integrity of these sensory structures, leading to progressive degeneration of hair cells and photoreceptors over time.

Video: Genetics 101

Chromosome location

USH2A is located on the long arm of chromosome 1 at position 1q41. The gene spans a large genomic region and encodes a transcript that produces a protein of 5202 amino acids, making usherin one of the larger proteins in the human proteome. The substantial size of both the gene and its protein product contributes to the complexity of genetic analysis and the diversity of pathogenic variants observed.

Protein structure

Usherin is a large extracellular protein with a modular architecture composed of multiple functional domains. The N-terminal region contains a Laminin N-terminal domain (amino acids 271-517), followed by a series of ten Laminin EGF-like domains spanning amino acids 518 to 1052. These laminin-related domains are thought to facilitate interactions with other basement membrane components and cell-surface receptors. The central and C-terminal portions of the protein feature four Fibronectin type-III domains (amino acids 1058-1468), which typically mediate protein-protein interactions and contribute to the structural framework of the extracellular matrix. This domain organisation reflects usherin's role in assembling and maintaining the complex molecular networks required for proper function of sensory epithelia.

Domain map · 5,202 amino acids
Laminin N-terminal (271-517)Fibronectin type-III 3 (1245-1363)Fibronectin type-III 4 (1364-1468)Laminin G-like 1 (1517-1709)Laminin G-like 2 (1714-1891)Fibronectin type-III 15 (2820-2923)Fibronectin type-III 25 (3964-4067)Fibronectin type-III 27 (4157-4261)Laminin N-terminal271-517Laminin G-like 11517-1709Laminin G-like 21714-18911~2,6015,202
Domain - independent functional unit
🧬 Explore 3D structure on AlphaFold
UniProt:O75445Length:5,202 aaStructure:AlphaFold

Key variants

Over 400 pathogenic variants have been identified in USH2A, making it one of the most commonly affected genes in hereditary hearing and vision loss. The large size of the gene means that variants can occur throughout its coding sequence, including missense changes, nonsense mutations, and splice-site alterations. Pathogenic variants generally lead to reduced or absent functional usherin protein, disrupting basement membrane integrity in the inner ear and retina.

The table below shows the top 10 pathogenic or likely-pathogenic variants currently classified in ClinVar for USH2A.
View all on ClinVar →

Sample of pathogenic variants

10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.

Variant (HGVS) Protein change Classification Evidence Associated condition
c.1387_1405del
Deletion
p.Tyr463fs Pathogenic/Likely pathogenic ★★☆☆ Usher syndrome type 2A
c.1409_1419del
Deletion
p.Phe470fs Pathogenic/Likely pathogenic ★★☆☆ USH2A-related disorder
c.14782C>T
single nucleotide variant
p.Gln4928Ter Pathogenic/Likely pathogenic ★★☆☆ Usher syndrome type 2A
c.250del
Deletion
p.Cys84fs Pathogenic ★★☆☆ USH2A-related disorder
c.545_548del
Deletion
p.Lys182fs Pathogenic ★★☆☆ Usher syndrome type 2A
c.5933_5940del
Deletion
p.Pro1978fs Pathogenic ★★☆☆ USH2A-related disorder
c.5950_5960dup
Duplication
p.Tyr1987Ter Pathogenic ★★☆☆ USH2A-related disorder
c.9433_9437delinsAGGAGATCATATCCATTCCATAGGA
Indel
p.Leu3145fs Pathogenic/Likely pathogenic ★★☆☆ USH2A-related disorder
c.10695T>A
single nucleotide variant
p.Tyr3565Ter Pathogenic ★☆☆☆ USH2A-related disorder
c.131del
Deletion
p.Gly44fs Pathogenic ★☆☆☆ Retinal disorder

Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.

Associated conditions

Pathogenic variants in USH2A are associated with two main clinical presentations. Usher syndrome type 2 is the most common manifestation, characterised by moderate to severe congenital hearing loss and progressive retinitis pigmentosa that typically becomes apparent in adolescence or early adulthood. USH2A variants are responsible for the majority of Usher syndrome type 2 cases. Additionally, USH2A pathogenic variants account for approximately 10 to 15 per cent of autosomal recessive retinitis pigmentosa cases without associated hearing loss, a condition in which light-sensing retinal cells gradually deteriorate, leading to progressive vision impairment.

UK clinical status

Within the NHS Genomic Medicine Service, USH2A is included on the Monogenic hearing loss panel (green classification, version R67) and the Retinal disorders panel (green classification, version R32). The green classification indicates strong evidence supporting the gene's role in these conditions, and variants in USH2A are routinely evaluated in clinical diagnostic pathways for patients presenting with hereditary hearing loss or retinal degeneration.

Frequently asked questions

What is the difference between Usher syndrome type 2 and retinitis pigmentosa caused by USH2A variants?

Usher syndrome type 2 involves both congenital hearing loss and progressive vision loss due to retinitis pigmentosa, whereas some individuals with USH2A variants experience retinitis pigmentosa alone without significant hearing impairment. The specific variants and possibly additional genetic or environmental factors may influence which presentation occurs.

How is USH2A inherited?

USH2A-related conditions follow an autosomal recessive pattern of inheritance. This means an individual must inherit pathogenic variants in both copies of the gene (one from each parent) to develop symptoms. Carriers with one pathogenic variant typically do not experience hearing or vision loss.

Can genetic testing for USH2A help with early diagnosis?

Genetic testing can identify pathogenic USH2A variants in individuals with hearing loss or a family history of Usher syndrome or retinitis pigmentosa, enabling earlier monitoring for retinal degeneration and access to supportive interventions. Early diagnosis allows for timely referral to specialist services and appropriate planning for managing progressive sensory changes.

References

  1. Blanco-Kelly F, Jaijo T, Aller E. Clinical aspects of Usher syndrome and the USH2A gene in a cohort of 433 patients. JAMA ophthalmology. 2015. PMID: 25375654
  2. Chen X, Sheng X, Liu X. Targeted next-generation sequencing reveals novel USH2A mutations associated with diverse disease phenotypes: implications for clinical and molecular diagnosis. PloS one. 2014. PMID: 25133613
  3. McGee TL, Seyedahmadi BJ, Sweeney MO. Novel mutations in the long isoform of the USH2A gene in patients with Usher syndrome type II or non-syndromic retinitis pigmentosa. Journal of medical genetics. 2010. PMID: 20507924
  4. Sandberg MA, Rosner B, Weigel-DiFranco C. Disease course in patients with autosomal recessive retinitis pigmentosa due to the USH2A gene. Investigative ophthalmology & visual science. 2008. PMID: 18641288
  5. Liu X, Bulgakov OV, Darrow KN. Usherin is required for maintenance of retinal photoreceptors and normal development of cochlear hair cells. Proceedings of the National Academy of Sciences of the United States of America. 2007. PMID: 17360538
  6. van Wijk E, Pennings RJ, te Brinke H. Identification of 51 novel exons of the Usher syndrome type 2A (USH2A) gene that encode multiple conserved functional domains and that are mutated in patients with Usher syndrome type II. American journal of human genetics. 2004. PMID: 15015129
  7. Bhattacharya G, Miller C, Kimberling WJ. Localization and expression of usherin: a novel basement membrane protein defective in people with Usher's syndrome type IIa. Hearing research. 2002. PMID: 11788194
  8. Adam MP, Bick S, Mirzaa GM. Usher Syndrome Type II. 1993. PMID: 20301515
Educational content. This page is not medical or genetic advice, is not individually reviewed by a clinician for each reader, and should not replace a consultation with a qualified healthcare professional or genetic counsellor. If you are considering genetic testing or acting on a test result, book a consultation.
Data sources Last updated 17 April 2026. Content compiled from HGNC · MedlinePlus Genetics · ClinGen · Genomics England PanelApp · NHS National Genomic Test Directory · ClinVar · UniProt · AlphaFold .